Anti-PLC-p2, -p4, -yl, -y2, -61, and -62 antibodies had no effect. Preincubation of the membranes with an antibody raised against the COOH terminus of the a-subunit of G/ii proteins inhibited PLC activity in response to all three different receptor agonists to a similar extent, whereas anti-Gicxl-2 and anti-Gicx3 antibodies had no effect. In conclusion, the data of the present study indicate that CCK-8 and carbachol activate PLC-pi and PLC-p3, respectively, whereas bombesin activates both PLC-pl and PLC-p3. Activation of PLC-p by these receptor agonists is mediated by Gq/ll. cholecystokinin; phospholipase C-p; signal transduction THREE CLASSES of phosphatidylinositol-specific phospholipase C (PLC) isoenzymes, designated PLC-p, PLC-y, and PLC-6, are products of separate genes (29). Heptahelical receptors, including several hormone and neurotransmitter receptors, activate PLC-p via heterotrimeric GTP-binding proteins (G proteins) (29). The PLC-p isoenzymes currently comprise four subentities (PLCpl-*). In reconstituted systems, a-subunits of pertussis toxin-and cholera toxin-insensitive G proteins of the G, family activate PLC-p l-4 (8-10, 15, 19, 29, 35, 41), whereas G protein py-subunit activates PLC&, PLCp3, and, to a smaller extent, PLC-pl (3, 8, 11). Whereas activation of PLC-p isoenzymes by different G protein (x-and py-subunits has been extensively studied in reconstituted systems, much less information exists concerning receptor-mediated activation of PLC isoenzymes in the natural membrane environment.
Recent evidence argues for an organized interaction of receptors, G proteins, and effecters, because in vivo a particular receptor selectively activates G proteins consisting of a distinct composition of W, p-, and y-subunits (12-14). It is likely that selectivity also exists for the ability of a receptor to activate a subset of PLC isoenzymes. This has been suggested by a recent study in smooth muscle membranes showing that cholecystokinin octapeptide (CCK-8) activates PLC-pi via Gg/ll, whereas adenosine stimulates PLC& via Gi3 (22,23).
In the present study, we investigated whether a similar specificity of a receptor for a particular subset of PLC-p isoenzymes exists in pancreatic acinar membranes. Therefore, immunoneutralizing antibodies raised against the different isoforms of PLC-p and against the COOH-terminal part of G protein cx-subunits were used to study differential activation of PLC-p isoenzymes by the PLC-activating agonists CCK-8, carbachol, and bombesin, which bind to different receptor entities (9). Pancreatic acinar cells express receptors for CCK-A, M4, and gastrin-releasing peptide (9). The dat a show that PLC-&, -p3, -yl, and -& are present in' pancreatic acinar membranes.
CCK-8 and carbachol activate PLC& and -p3, respectively. Bombesin activates both PLC-p isoenzymes to a similar extent. CCK-8-, carbachol-, and bombesin-induced activation of PLC-p1 and -p3 is mediated via Gqill proteins. Effect of anti-GqlII a and anti-G,a antibodies on agonist-induced PLC activity. Pancreatic acini are known to express the pertussis toxin-sensitive G proteins G,i, G12, G,3, and G, (231, as well as the cholera and pertussis toxin-insensitive G protein G, (26). Pretreatment of isolated pancreatic acini for 4 h with pertussis toxin (20 pg/ml) has no effect on inositol phosphate accumulation in response to the CCK-8 analogue caerulein (211, carbachol, or bombesin (data not shown). Thus G proteins of the cholera toxin-and pertussis toxin-insensitive family G, rather than G, and G, are likely to couple the respective receptors to phosphoinositide hydrolysis. To study the G proteins mediating agonist-induced PLC activation more directly, PLC activity was measured in isolated pancreatic acinar membranes preincubated with antibodies raised against the COOH-terminal part of a-subunits of G proteins. An antibody raised against the o-subunit of Gq and Gii bound to a 42-kDa substrate in pancreatic acinar membranes (Fig. 1A) . As shown in Fig. 2 , CCK-8 (10 nM), bombesin (100 nM), and carbachol (10 pM) increased basal PLC activity in pancreatic acinar membranes 3.0-, 3.3-, and 4.0-fold, respectively (n. = 5). Preincubation of the membranes with this antibody inhibited PLC activation by all three different receptor agonists with similar potency (CCK-8, 60%; carbachol, 55%; bombesin, 46%; Fig. 2) . A similar inhibitory effect of the anti-Gdna antibody was observed at lower concentrations of these receptor agonists (data not shown). Half-maximal inhibition of CCK-g-induced PLC activation was observed at an antibody concentration of 10 pg IgG/ml (data not shown). An antibody raised against an internal sequence of G,,ii (Y had no effect on CCK-8-induced PLC activation (data not shown). In contrast, anti-G,aiez and anti-G,03 antibody, which cross-reacts with Goo, had no effect on agonist-stimulated PLC (Fig. 2) . Thus these data suggest that activation of PLC-pi and -p3 by the three different receptor agonists is mediated by Gqlli proteins. Effect of. anti-PLC antibodies on CCK&, bombesin-, and carbachol-induced PLC activity. Western blot analyses revealed the presence of PLC&, -p3, -yl, and -S1 in pancreatic acinar membranes, whereas PLC-p2, -p4, -y2, and -S2 were not detectable (Fig. 1B) .
MATERIALS
Anti-PLC antibodies were tested for their ability to inhibit agonist-induced PLC activation. Polyclonal anti-PLC-p antibodies showed differential effects on agonistinduced activation of PLC (Fig. 3) . The order of sensitiv- *P < 0.05; ***P < 0.001; ns, not significant.
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ity of agonist-stimulated PLC activity toward inhibition by anti-PLC-P1 antibody was CCK-8 (77% inhibition, P < 0.001) > bombesin (62% inhibition, P < 0.001) > carbachol (21% inhibition, P < 0.05). Half-maximal inhibition of CCK-B-induced PLC activation was observed at an anti-PLC-Pi antibody concentration of 0.3 pg IgG/ml (Fig. 4A) . A similar result was obtained when membranes were preincubated with a mixed monoclonal anti-PLC-P1 antibody, confirming that the inhibitory effect of the anti-PLC& antibody was specific. Preincubation of the membranes with anti-PLC& antibody strongly reduced carbachol (10 pM)-induced PLC activity (64% inhibition, P < 0.001) and partially inhibited bombesin (100 nM)-induced PLC activation (39% inhibition, P < 0.001; Fig. 3 ). CCK-8 (10 nM)-induced PLC activity was not significantly influenced by the anti-PLC-ps antibody, indicating that the inhibitory effect of this antibody on carbachol-and bombesininduced PLC activation was specific. Half-maximal inhibition of carbachol-induced PLC activation was observed at an anti-PLC-p3 antibody concentration of 0.4 ug IgG/ml (Fig. 4B) . Anti-PLC-P2, -p4, -yl, -y2, -S1, and -S2 antibodies had no effect on CCK-, carbachol-, or bombesin-induced PLC activation (Table 1) . Preincubation of the membranes with both anti-PLC-p1 and -p3 antibody (10 pg/ml each) led to an Data are means _ + SE of 3 independent experiments. Pancreatic acinar membranes were preincubated with anti-phospholipase C (PLC)+i, -pz, +3, +4, -yi, -y2, -61, and -62 antibodies at a concentration of 10 ug immunoglobulin G/ml or the appropriate amount of normal rabbit serum (control) for 2 h at 4°C before assessment of PLC activation in response to CCK-8 (10 nM), carbachol(l0 PM), and bombesin (100 nM).
almost complete inhibition of CCK-8 (10 nM)-, carbachol (10 PM)-, and bombesin (100 nM)-induced PLC activity (Fig. 3) , suggesting selective and exclusive activation of PLC-p1 and -p3 by CCK-8, carbachol, and bombesin.
DISCUSSION
Activation of PLC-p isoenzymes by different G protein a-and py-subunits has been extensively studied in reconstituted systems (for review see Ref. 29). Much less is known about the pattern of PLC isoenzymes activated by an individual receptor under in situ conditions. Evidence for organized interactions of receptors, G proteins, and effecters derives from several sources (25). G protein-coupled receptors appear to interact functionally with distinct "pools" of G proteins (6, 34), and the specificity of signaling by G proteins appears to be more pronounced in vivo (12-14) than in reconstituted systems (16,30). For instance, it has been shown that in vivo a particular receptor selectively activates G proteins consisting of distinct composition of a-, p-, and y-subunits (12-14). Recently, expression of the a2-adrenergic receptor and G proteins in NIW3T3 cells and PC-12 cells revealed different effectiveness of signal transfer from receptor to G protein in the two different cell membranes (31). These data indicate that factors other than the expression of a particular G protein @y-subunit heterotrimer modulate agonistinduced activation of G proteins in a cell-specific fashion.
In the present study, immunoneutralizing antibodies raised against the different isoforms of PLC-p and against the COOH-terminal part of G protein cx-subunits were used to investigate differential activation of PLC-p isoenzymes in isolated pancreatic acinar membranes. The data show that CCK-8 and carbachol activate PLC-p1 and PLC-p3, respectively, whereas bombesin activates both PLC-p isoenzymes to a similar extent. Rat pancreatic acini express the CCK-A, Mq, and the gastrin-releasing peptide receptor (bombesin receptor), which have been cloned and belong to the class of heptahelical receptors (9). The contention that the CCK receptor is coupled to PLC-p1 is supported by recent studies showing that CCK-8-induced activation of PLC is inhibited by an anti-PLC& antibody in smooth muscle membranes (22, 23) and that anti-PLC-p1 antibody inhibits CCK-8-induced amylase release from streptolysin 0-permeabilized pancreatic acini (37). The PLC isoenzymes generate different portions of cyclic inositol phosphates (33). A previous study showing that carbachol and bombesin induce formation of different portions of cyclic to noncyclic inositol phosphates in pancreatic minilobules provides further indirect evidence that carbachol and bombesin activate different PLC isoenzymes (33).
The finding that CCK-8, carbachol (present study), and adenosine (via the Al receptor) (22) activate distinct PLC-p isoenzymes suggests that other PLCcoupled receptors also activate a distinct subset of PLC-p isoenzymes. The functional implication of differential PLC isoenzyme activation is unclear. It is interesting to note that acetylcholine and CCK evoke different patterns and spatial organization of Ca2+ oscillations in pancreatic acinar cells (18). An attractive idea is that activation of distinct PLC isoenzymes induces a distinct pattern of Ca2+ signaling.
In pancreatic acinar membranes the anti-Gq,ilcr antibody inhibited activation of PLC by CCK-8, bombesin, and carbachol approximately to the same extent. Partial inhibition is suggestive of other operative pathways. Anti-Gia and anti-G,cx antibodies had no effect on CCK-8-, carbachol-and bombesin-induced PLC activity, and pertussis toxin-pretreatment of pancreatic acini did not alter activation of PLC by CCK-8 (21), carbachol, or bombesin (data not shown). In addition to G,cx and Gii(~, a-subunits of G14, G15, and G16 proteins activate PLC-p (41). G 14~ is expressed in a variety of cells (40) and could therefore be involved in agonistinduced activation of PLC-p1 in pancreatic acini. However, anti-G14cx antibody was not available in the present study. The expression of G15 and G16 proteins appears to be restricted to hematopoetic cells (40), excluding the possibility that these G proteins participate in regulation of PLC-p isoenzymes in pancreatic acini. Another possibility is that &subunits of G proteins partly mediate agonist activation of PLC-p isoenzymes in pancreatic acinar membranes. G protein py-subunit has been reported to activate PLC-p3 as well as PLC-pi and PLC-p2 (35). However, the high number of G protein p-and y-subtypes makes it difficult to determine the exact subunit composition of the G protein heterotrimer(s)
counling an individual receptor to a distinct PLC-p isoenzyme by PLC assay and immunoneutralizing antibodies. Partial inhibition of agonist-induced PLC activation may also be due to incomplete immunoneutralization of Gq,ll~. Immunoneutralization of G proteins by antibodies raised against the COOH-terminus of G protein <x-subunits is an established method to probe for involvement of a G protein in signal transduction (22, 23). These antibodies abolish interaction and thus activation of G proteins by receptors (7). The finding that an antibody raised against the COOH-terminus of a-subunit of Gqill protein inhibited activation of PLC in response to all three different receptor agonists, although CCK-8 activates PLC-p1 and carbachol activates PLC&, suggests that the coupling of different receptors to different PLC isoenzymes is mediated by the same G protein, i.e., G 9/11. Gs(x and Gncx share indistinguishable properties for activation of PLC-p1 and -p3 in vitro (8). Moreover, multiple combinations of G protein py-subunits were uniformly active on PLC-p3 (38). This raises the important question of what confers receptor-effector specificity in situ. A possibility is that specific receptors and distinct PLC isoenzymes are colocalized. In this localized environment, activation of G proteins would lead to activation of a certain PLC-p isoenzyme. Evidence supporting this assumption comes from experiments that demonstrate that PLC is a guanosine triphosphatase (GTPase)-activating protein (GAP) for G, (1) . The observations that the induced GTPase activity exceeded the bulk rate of guanine nucleotide exchange and that hydrolysis of only a portion of the Gs GTP was stimulated suggest that this GAP activity is due to a subpopulation of receptors and G, proteins, which are in close association, with rapid turnover. Membrane organization of receptors, G proteins, and effecters may be facilitated by interaction with cytoskeletal elements (2% A-further hypothesis is that signaling specificity is determined in part by proteins found in the receptor's microenvironment, which, together with the receptor, G protein, and effector, contribute to the formation of a signal-transduction complex at the cytoplasmic face of the receptor. This hypothesis is consistent with data showing the existence of multimeric G protein complexes and the isolation of receptor or G protein subunits together with some effecters (5,20,24,39).
In conclusion, the results of the present study demonstrate strong selectivity of particular receptors for PLC-p subtypes. The data show that CCK-8 and carbachol activate PLC-p1 and PLC-p3, respectively, whereas bombesin activates PLC-p1 and -p3 to a similar extent. CCK&, carbachol-, and bombesin-induced activation of PLC-pi and -p3 depends on Gq/ii.
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